Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 10, 2011, Pages 1159-1162

  Stromdahl H ^a   Tham, J ^a,d   Melander, E ^a,b   Walder, M ^a   Edquist, P J ^c   Odenholt, I ^a  

^a LUND UNIVERSITY   (Sweden)

^b Laboratory Medicine   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CIPROFLOXACIN; COTRIMOXAZOLE; CTX M 1 ENZYME; CTX M 9 ENZYME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HUMAN; MALE; MOLECULAR PHYLOGENY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; ESCHERICHIA COLI; FECES; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMAN EXPERIMENTATION; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SWEDEN;

EID: 80054774990     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1202-5     Document Type: Article

References (13)

1. G Kahlmeter 2008 Breakpoints for intravenously used cephalosporins in Enterobacteriaceae-EUCAST and CLSI breakpoints Clin Microbiol Infect 14 Suppl 1 169 174 18154542 10.1111/j.1469-0691.2007.01856.x 1:CAS:528:DC%2BD1cXhtleiu7k%3D
2. DL Paterson RA Bonomo 2005 Extended-spectrum beta-lactamases: a clinical update Clin Microbiol Rev 18 4 657 686 16223952 10.1128/CMR.18.4.657-686.2005 1:CAS:528:DC%2BD2MXht1Wrsr%2FE
3. JD Pitout KB Laupland 2008 Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 3 159 166 18291338 10.1016/S1473-3099(08)70041-0 1:CAS:528:DC%2BD1cXjsl2gsbg%3D
4. European Antimicrobial Resistance Surveillance System (EARSS) (2010) Home page at: http://www.rivm.nl/earss/database/. Accessed 16 April 2010
5. J Tham I Odenholt M Walder A Brolund J Ahl E Melander 2010 Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea Scand J Infect Dis 42 4 275 280 20121649 10.3109/00365540903493715 1:CAS:528:DC%2BC3cXjtFKitb8%3D
6. E Lautenbach JB Patel WB Bilker PH Edelstein NO Fishman 2001 Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes Clin Infect Dis 32 8 1162 1171 11283805 10.1086/319757 1:CAS:528: DC%2BD3MXjslKnsLo%3D
7. J Rodríguez-Baño L López-Cerero MD Navarro P Díaz de Alba A Pascual 2008 Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology J Antimicrob Chemother 62 5 1142 1149 18641033 10.1093/jac/dkn293
8. Molstad S, Cars O, Struwe J (2008) Strama-a Swedish working model for containment of antibiotic resistance. Euro Surveill 13(46). pii: 19041
9. Swedish Institute for Infectious Disease Control (2010) Extended spectrum beta-lactamase (ESBL). Available online at: http://www.smi.se/in-english/ statistics/extended-spectrum-beta-lactamase-esbl/. Accessed 25 October 2010
10. Kahlmeter G. The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M). SRGA's methods
11. Wollin HH (2002) Infektionsdiagnostik 1:2: Infektioner i mag- och tarmkanalen. Smittskyddsinstitutet, Sweden, p 282
12. A Melhus 1996 Juhlin's medium, a selective and differential medium for gram-negative rods Med Microbiol Lett 5 74 81
13. JK Rasheed C Jay B Metchock F Berkowitz L Weigel J Crellin C Steward B Hill AA Medeiros FC Tenover 1997 Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia Antimicrob Agents Chemother 41 3 647 653 9056008 1:CAS:528: DyaK2sXhsFKnt7Y%3D